Exozymes Inc. has been selected as a core industry partner in the Meta-PURE initiative, a $9.2 million project funded by the National Science Foundation (NSF) under the CFIRE program. The initiative, led by Georgia Tech and involving a coalition of top academic and industry groups, aims to advance modular cell-free biomanufacturing. Exozymes Inc. will receive a $3 million share of the funding to develop a cell-free ATP-generating module, which will serve as a power plant for various chemical production modules. The company's involvement also includes creating a production module for santalene, a high-value fragrance compound. The project emphasizes the development of standardized, interoperable modules for diverse applications, enhancing the scalability and accessibility of cell-free systems.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。